Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Mar/12/2022 17 1
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Teniposide Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021 3 0
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Grazoprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021 4 1
Bemcentinib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021 2 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/04/2021 3 0
Telaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 4 0
Atazanavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 6 1
Excel (.xslx) CSV (.csv)